Phosphate Binders in CKD: ‟New Kids on the Block”
DOI:
https://doi.org/10.53778/pjkd31089Nøgleord:
hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxideResumé
Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.
Downloads
Publiceret
Nummer
Sektion
Licens
Ophavsret (c) 2021 Muhammad Umair Afzal, Shafeeq Cheema

Dette værk er udgivet under licensen Creative Commons Kreditering–IkkeKommerciel (CC BY-NC).
